RETRACTED: ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC).

Authors :: Shi Y
Wu L
Yu X
Xing P
Zhou J
Wang A
Shi J
Hu Y
Wang Z
An G
Fang Y
Sun S
Zhou C
Wang C
Ye F
Li X
Wang J
Wang M
Liu Y
Zhao Y
Source :: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Dec; Vol. 31 Suppl 7, pp. S1428. Date of Electronic Publication: 2020 Dec 13.
Publication Year :: 2020
Abstract: This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article was retracted at the request of the authors. The authors of this abstract have advised that full agreement between authors and sponsors on publication of the abstract has not been reached and they are therefore unable to publish this data at present.<br /> (Copyright © 2021. Published by Elsevier Ltd.)

Language :: English
ISSN :: 1569-8041
Volume :: 31 Suppl 7
Database :: MEDLINE
Journal :: Annals of oncology : official journal of the European Society for Medical Oncology
Publication Type :: Academic Journal
Accession number :: 33517977
Full Text :: https://doi.org/10.1016/j.annonc.2020.10.517

Full Text Access

Tools